SYNTA Ganetespib (STA-9090) NSCLC (#453)
Laufzeit: 01.01.2011 - 31.12.2018
imported
Kurzfassung
A randomized phase IIB/III study of Ganetespib (STA-9090) in combination with Docetaxel versus Docetaxel alone in subjects with stage IIIB or IV Non-Small-Cell Lung Cancer
